The designation of the Swiss Authorised Representative (CH REP) is required to market all Medical Devices, including legacy devices, i.e. devices covered by a certificate still valid in compliance with the MDD / AIMDD Directives and class I devices that will require the intervention of a Notified Body (ON) which can continue to be made available on the market or put into service until May 27, 2025.
THEMA SWISS NEWS
Do you want to stay updated on the main news regarding the Switzerland – EU Agreement in the field of Medical Devices?
Fill out the form and receive periodically our THEMA: SWISS NEWS by email!